Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

New funding decisions by NHS England

The NHS announced its plan to provide the latest innovative treatments for patients, just days after it celebrated its 70th anniversary. Treatments are grouped into five levels of priority, with those that cost less and offer more clinical benefit for patients relative to the other treatments being considered classified as level one, and treatments with the lowest relative clinical benefit and highest cost placed in the lowest category (level five).

There is sufficient funding available in this round to approve treatments in levels one to three.  The remaining three treatments can be considered in the next prioritisation round in November 2018 and if successful could be funded in the 2019/20 financial year.

See full details here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.